Research Article
Bifidobacterium animalis ssp. lactis 420 Protects against Indomethacin-Induced Gastric Permeability in Rats
Table 2
Prevalence of gastric lesions.
| |||||||||||||||||||||||||||||||||||
aThe treatment groups were control, indomethacin-challenged group (NSAID), and a probiotic group supplemented daily with 1010 colony forming units of Bifidobacterium lactis 420 for seven days prior to indomethacin challenge. The lesion Grades I, II, and III represent mild, moderate, and severe lesions, respectively. bANOVA P < 0.05 when compared with control. |